Robert E. Akins, Jr., Ph.D., Committee Chair
Mary McElwain, Committee Coordinator
Phone: (302) 651-6779
Email: biosafety@nemours.org
The Institutional Biosafety Committees (IBC) at Nemours oversees the use of recombinant DNA, infectious agents, and biohazardous materials in the course of research. To assure proper oversight, Principal Investigators (PIs) must register their research projects with the IBC prior to funds being made available for the project. Click one of the links below for more information.
- Procedure for registering research projects with the IBC
- Summary of Biosafety Levels - 2011
- Roles and responsibilities of the PI, the institution, and the IBC
- NIH Guidelines for Research Involving Recombinant DNA Molecules
- CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL)
- OSHA Bloodborne Pathogens Standard
- LSC Room Label - Associated Biosafety Precautions for Procedure Room
Additional Resources
- IBC Roster, Charter, and Operating Procedures
- Schedule for Upcoming IBC Meetings
- Minutes of Past Meetings - **Minutes are available upon request
- A Lab Biosafety Primer from CDC
- Shipping Biohazardous Material
- Institutional Biosafety Manual
- Safety Rounding Research Tracer
If you have any questions or concerns please email us at biosafety@nemours.org